BUD 0.00% 0.6¢ buddy technologies ltd

Ann: Umps Health First Commercial Licensee of LIFX Technology, page-40

  1. 7,212 Posts.
    lightbulb Created with Sketch. 613
    Now if you had reoccurring revenue from OHM it wouldn't matter at all, SP would be at $2 if OHM was successful with the LIFX acquisition. That's the SP difference due to the OHM failure, that's how much OHM is still affecting this company.

    Need that reoccurring revenue from OHM going and watch it fly, OHM is the key not LIFX, all IMO.
 
watchlist Created with Sketch. Add BUD (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.